- Home
- CELH vs LEGN Comparison
CELH vs LEGN Comparison
Compare CELH & LEGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CELH
- LEGN
- Stock Information
- Founded
- CELH 2004
- LEGN 2014
- Country
- CELH United States
- LEGN United States
- Employees
- CELH N/A
- LEGN N/A
- Industry
- CELH Beverages (Production/Distribution)
- LEGN Biotechnology: Pharmaceutical Preparations
- Sector
- CELH Consumer Staples
- LEGN Health Care
- Exchange
- CELH Nasdaq
- LEGN Nasdaq
- Market Cap
- CELH 7.5B
- LEGN 7.0B
- IPO Year
- CELH N/A
- LEGN 2020
- Fundamental
- Price
- CELH $39.39
- LEGN $27.78
- Analyst Decision
- CELH Buy
- LEGN Strong Buy
- Analyst Count
- CELH 17
- LEGN 13
- Target Price
- CELH $47.53
- LEGN $75.67
- AVG Volume (30 Days)
- CELH 7.1M
- LEGN 1.5M
- Earning Date
- CELH 05-06-2025
- LEGN 05-13-2025
- Dividend Yield
- CELH N/A
- LEGN N/A
- EPS Growth
- CELH N/A
- LEGN N/A
- EPS
- CELH 0.32
- LEGN N/A
- Revenue
- CELH $1,329,198,000.00
- LEGN $728,303,000.00
- Revenue This Year
- CELH $57.42
- LEGN $65.96
- Revenue Next Year
- CELH $21.56
- LEGN $52.55
- P/E Ratio
- CELH $121.26
- LEGN N/A
- Revenue Growth
- CELH N/A
- LEGN 112.46
- 52 Week Low
- CELH $21.10
- LEGN $29.27
- 52 Week High
- CELH $98.85
- LEGN $60.87
- Technical
- Relative Strength Index (RSI)
- CELH 67.31
- LEGN 29.61
- Support Level
- CELH $32.36
- LEGN $30.25
- Resistance Level
- CELH $39.94
- LEGN $33.30
- Average True Range (ATR)
- CELH 1.64
- LEGN 1.78
- MACD
- CELH 0.27
- LEGN -0.57
- Stochastic Oscillator
- CELH 92.74
- LEGN 5.19
About CELH Celsius Holdings Inc.
Celsius Holdings plays in the energy drink subsegment of the global nonalcoholic beverage market, with 96% of revenue concentrated in North America. Celsius' products contain natural ingredients and a metabolism-enhancing formulation, appealing to fitness and active lifestyle enthusiasts. The firm's portfolio includes its namesake Celsius Originals beverages, Celsius Essentials line (containing aminos), and Celsius On-the-Go powder packets. Celsius dedicates its efforts to branding and innovation, while it utilizes third parties for the manufacturing, packaging, and distribution of its products. In 2022, Celsius forged a 20-year distribution agreement with PepsiCo, which holds an 8.5% stake in the business.
About LEGN Legend Biotech Corporation
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's lead product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.